These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24909277)

  • 41. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
    Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice.
    Roupie V; Romano M; Zhang L; Korf H; Lin MY; Franken KL; Ottenhoff TH; Klein MR; Huygen K
    Infect Immun; 2007 Feb; 75(2):941-9. PubMed ID: 17145953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
    Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
    Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X; Gao Q; Fu R
    Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene.
    Yao W; Liu S; Qu X; Xiao S; Liu Y; Liu J
    J Med Microbiol; 2009 Apr; 58(Pt 4):462-468. PubMed ID: 19273642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.
    Olsen AW; Williams A; Okkels LM; Hatch G; Andersen P
    Infect Immun; 2004 Oct; 72(10):6148-50. PubMed ID: 15385521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
    Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
    Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
    Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
    J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof].
    Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral immune responses in mice immunized with region of difference DNA vaccine constructs of pUMVC6 and pUMVC7.
    Hanif SNM; Mustafa AS
    Int J Mycobacteriol; 2017; 6(3):281-288. PubMed ID: 28776528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide.
    Garnica O; Das K; Devasundaram S; Dhandayuthapani S
    Tuberculosis (Edinb); 2019 May; 116S():S34-S41. PubMed ID: 31064713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
    Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
    Pardini M; Giannoni F; Palma C; Iona E; Cafaro A; Brunori L; Rinaldi M; Fazio VM; Laguardia ME; Carbonella DC; Magnani M; Ensoli B; Fattorini L; Cassone A
    FEMS Microbiol Lett; 2006 Sep; 262(2):210-5. PubMed ID: 16923077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens.
    Grover A; Ahmed MF; Singh B; Verma I; Sharma P; Khuller GK
    Microbes Infect; 2006 Aug; 8(9-10):2390-9. PubMed ID: 16962360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The recombinant fusion protein CFP10-ESAT6-dIFN has protective effect against tuberculosis in guinea pigs.
    Permyakova NV; Belavin PA; Pirozhkova DS; Ufimtseva EG; Rozov SM; Mursalimov SR; Sidorchuk YV; Uvarova EA; Zagorskaya AA; Marenkova TV; Bannikova SV; Demidov EA; Starostin KV; Kravchenko MA; Vakhrusheva DV; Berdnikov RB; Eremeeva NI; Skornyakov SN; Peltek SE; Deineko EV
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):39-58. PubMed ID: 29243495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice.
    Sun L; Yuan Q; Xu T; Yao L; Feng J; Ma J; Wang L; Lv C; Wang D
    Biotechnol Lett; 2017 Aug; 39(8):1159-1166. PubMed ID: 28470626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation.
    Tollefsen S; Tjelle T; Schneider J; Harboe M; Wiker H; Hewinson G; Huygen K; Mathiesen I
    Vaccine; 2002 Sep; 20(27-28):3370-8. PubMed ID: 12213407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.